Literature DB >> 18190658

The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.

D E Schaubel1, C S Sima, N P Goodrich, S Feng, R M Merion.   

Abstract

The survival benefit of liver transplantation depends on candidate disease severity, as measured by MELD score. However, donor liver quality may also affect survival benefit. Using US data from the SRTR on 28 165 adult liver transplant candidates wait-listed between 2001 and 2005, we estimated survival benefit according to cross-classifications of candidate MELD score and deceased donor risk index (DRI) using sequential stratification. Covariate-adjusted hazard ratios (HR) were calculated for each liver transplant recipient at a given MELD with an organ of a given DRI, comparing posttransplant mortality to continued wait-listing with possible later transplantation using a lower-DRI organ. High-DRI organs were more often transplanted into lower-MELD recipients and vice versa. Compared to waiting for a lower-DRI organ, the lowest-MELD category recipients (MELD 6-8) who received high-DRI organs experienced significantly higher mortality (HR = 3.70; p < 0.0005). All recipients with MELD > or =20 had a significant survival benefit from transplantation, regardless of DRI. Transplantation of high-DRI organs is effective for high but not low-MELD candidates. Pairing of high-DRI livers with lower-MELD candidates fails to maximize survival benefit and may deny lifesaving organs to high-MELD candidates who are at high risk of death without transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18190658     DOI: 10.1111/j.1600-6143.2007.02086.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  79 in total

1.  Transplantation: Sharing of donated livers is not equal.

Authors:  Richard B Freeman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

2.  Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit.

Authors:  Colleen L Jay; Anton I Skaro; Daniela P Ladner; Edward Wang; Vadim Lyuksemburg; Yaojen Chang; Hongmei Xu; Sandhya Talakokkla; Neehar Parikh; Jane L Holl; Gordon B Hazen; Michael M Abecassis
Journal:  Liver Transpl       Date:  2012-06       Impact factor: 5.799

3.  Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.

Authors:  Jennifer E Layden; Scott J Cotler; Shellee A Grim; Michael J Fischer; Michael R Lucey; Nina M Clark
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

Review 4.  Development of organ-specific donor risk indices.

Authors:  Sanjeev K Akkina; Sumeet K Asrani; Yi Peng; Peter Stock; W Ray Kim; Ajay K Israni
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

5.  MELD as a metric for survival benefit of liver transplantation.

Authors:  Xun Luo; Joseph Leanza; Allan B Massie; Jacqueline M Garonzik-Wang; Christine E Haugen; Sommer E Gentry; Shane E Ottmann; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-02-19       Impact factor: 8.086

6.  Outcomes following liver transplantation in intensive care unit patients.

Authors:  Lena Sibulesky; Michael G Heckman; C Burcin Taner; Juan M Canabal; Nancy N Diehl; Dana K Perry; Darren L Willingham; Surakit Pungpapong; Barry G Rosser; David J Kramer; Justin H Nguyen
Journal:  World J Hepatol       Date:  2013-01-27

Review 7.  Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Authors:  Maurizio Pompili; Giampiero Francica; Francesca Romana Ponziani; Roberto Iezzi; Alfonso Wolfango Avolio
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

Authors:  Hany Dabbous; Mohammad Sakr; Sara Abdelhakam; Iman Montasser; Mohamed Bahaa; Hany Said; Mahmoud El-Meteini
Journal:  World J Hepatol       Date:  2016-08-08

9.  Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.

Authors:  Sinziana Dumitra; Salleh I Alabbad; Jeffrey S Barkun; Teodora C Dumitra; Dimitrios Coutsinos; Peter P Metrakos; Mazen Hassanain; Steven Paraskevas; Prosanto Chaudhury; Jean I Tchervenkov
Journal:  HPB (Oxford)       Date:  2013-03-14       Impact factor: 3.647

Review 10.  A review of quality of life instruments used in liver transplantation.

Authors:  Colleen L Jay; Zeeshan Butt; Daniela P Ladner; Anton I Skaro; Michael M Abecassis
Journal:  J Hepatol       Date:  2009-07-28       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.